Moneycontrol PRO
Open App
you are here: HomeNewsTrendsHealth

As At-Home Tests Surge, Doubts Rise About Accuracy of Public COVID-19 Counts

Concerns have also emerged about the accuracy of the tests. The Food and Drug Administration said Tuesday that antigen tests detect the omicron variant, but not as effectively as they detect other variants.

December 30, 2021 / 06:25 PM IST
(Representational image)

(Representational image)

Millions of rapid at-home COVID-19 tests are flying off pharmacy shelves across the country, giving Americans an instant, if sometimes imperfect, read on whether they are infected with the coronavirus.

But the results are rarely reported to public health departments, exacerbating the long-standing challenges of maintaining an accurate count of cases at a time when the number of infections is surging because of the omicron variant.

At the minimum, the widespread availability of at-home tests is wreaking havoc with the accuracy of official positivity rates and case counts. At the other extreme, it is one factor making some public health experts raise a question that once would have been unthinkable: Do counts of coronavirus cases serve a useful purpose, and if not, should they be continued?

“Our entire approach to the pandemic has been case-based surveillance: We have to count every case, and that’s just not accurate anymore,” said Dr Marcus Plescia, chief medical officer at the Association of State and Territorial Health Officials, a national non-profit organisation representing public health agencies in the United States. “It’s just becoming a time where we’ve got to think about doing things differently.”

There is no comprehensive data on how many rapid tests are used every day, but experts say it is most likely far higher than the number of polymerase chain reaction, or PCR, tests, which are completed in a lab. PCR tests require more time to deliver results, which are reported publicly as aggregate totals.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

At least one at-home test company has implemented a system to report results directly to health authorities. And some local health departments have set up systems for people to report results from rapid at-home tests. But with such a voluntary system, it is possible that millions of tests per day are going unreported, estimates Mara Aspinall, an expert in biomedical diagnostics at Arizona State University who is also on the board of directors of OraSure, a maker of rapid COVID tests.

“We certainly don’t want to discourage testing; but at the same time, we can’t leave public health authorities blind,” Aspinall said. “They rely on this information to take proactive and reactive precautions. It’s a very fine balance.”

The quick rise of at-home testing could be a tipping point in a conversation that began for public health experts months ago. At issue is the feasibility of shifting to less frequent case reporting or a “sentinel surveillance” system like the one that public health officials use to track other diseases such as the flu, which relies on a network of health care centres that track instances of the virus. Overall case numbers are extrapolated based on those case numbers.

Concerns have also emerged about the accuracy of the tests. The Food and Drug Administration said Tuesday that antigen tests detect the omicron variant, but not as effectively as they detect other variants.

Daily case counts have played a central role in shaping policy responses throughout the pandemic. Cities have instituted mask mandates and closed schools or businesses in response to positivity rates based on daily case counts. In New York City, the public school system was shut down at one point when the positivity rate reached 3%.

Public health officials, as well as news outlets like The New York Times, continue to use daily case counts to paint an up-to-date picture of the pandemic.

But the case numbers have long been understood as artificially low because of limited access to testing and the prevalence of asymptomatic cases. And compiling those numbers is a labour-intensive task for already strained public health departments.

As a result, many states began shifting away from daily case tallies to reporting fewer times a week over the summer, as cases dropped. Some returned to more frequent reporting when case numbers went back up. But with the omicron variant fuelling a rapid surge in positive cases, states are finding that they can’t keep up. And with so many more cases unreported through at-home tests, there’s little incentive to try.

Dr Marcelle Layton, chief medical officer at the Council of State and Territorial Epidemiologists, said her organization had been talking with its members about shifting away from daily case counts, with many that are still doing daily reporting eager to make the shift in the coming months. Her organization has also been in contact with the Centers for Disease Control and Prevention about possible guidance that would direct states to limit daily case reporting. A CDC spokesperson said the agency did not have plans to change reporting guidance for states.

Tennessee announced last week that it would begin reporting COVID case data weekly, consistent with other infectious diseases. At-home testing and lags in reporting from health care facilities have made the state’s daily case counts inaccurate, the state’s health commissioner, Dr Lisa Piercey, said at a news conference last week.

“That’s not a sustainable way to do it in perpetuity,” she said, adding that “daily reporting of numbers is really not that relevant any more. It’s relevant for trends, but the actual number is not that accurate when you don’t know what you don’t know.”

The state will also begin reporting its test positivity rate based solely on PCR tests rather than including the limited number of rapid tests on which it receives reports.

“Everyone knew that this time was coming,” Layton said, adding that the shift was part of a move toward approaching COVID-19 as an endemic disease that the country would have to live with indefinitely, much like influenza.

(Author: Sophie Kasakove)/(c.2021 The New York Times Company)
New York Times
first published: Dec 30, 2021 06:25 pm
Sections
ISO 27001 - BSI Assurance Mark